Allergy & Clinical Immunology News

• Canadian Experts Concerned About H5N1 Data Reporting Delays Data delays can hinder real-time analysis of H5N1 changes and mitigation strategies, scientists say.
  Medscape Medical News, April 07, 2025
• Alert FDA Approves First and Only Therapy for IgG4-RD The CD19+ B-Cell targeted therapy reduced flare risk by 87% in a phase 3 clinical trial.
  Medscape Medical News, April 04, 2025
• How Office Props Improve Patient Outcomes Showing patients props and other visual aids improves recall of information, motivates patients, said doctors who have expanded their ‘black bags.’
  Medscape Medical News, April 04, 2025
• Early-Onset Atopic Dermatitis Raises Uveitis Risk in Kids A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis, highlighting a need for ophthalmologic monitoring in youth.
  Medscape Medical News, April 04, 2025
• PBM Private Labeling Boosts Biosimilars, Raises Concerns Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this consolidation of the drug supply chain could undercut competition.
  Medscape Medical News, April 03, 2025
• State and Local Funding Cuts Hit ID Hard Wide-ranging challenges include staffing, technology upgrades, community outreach.
  Medscape Medical News, April 03, 2025
• Canada Makes Headway in Managing PFAS The ‘State of Per- and Polyfluoroalkyl Substances (PFAS) Report’ concludes that the whole class of PFAS, except fluoropolymers, is harmful to human health and the environment.
  Medscape Medical News, April 03, 2025
• Steroid Delivery System for Rhinosinusitis May Improve Sleep A device that releases a corticosteroid into the sinonasal cavity when patients exhale may improve sleep quality in chronic rhinosinusitis, new research shows.
  Medscape Medical News, April 03, 2025
• Vaccination Slumps and Research Cuts Threaten Long-Term Public Health Low vaccination rates coupled with vanishing vaccine research and development will challenge ID experts.
  Medscape Medical News, April 02, 2025
• Intermittent Fasting Beats Calorie Cutting for Weight Loss A 4:3 nonconsecutive intermittent fasting regimen was more tolerable and yielded somewhat greater weight loss at 1 year than daily caloric restriction.
  Medscape Medical News, April 02, 2025
• Hormonal Contraceptives and Allergies: Is There a Link? The use of systemic hormonal contraceptives may be associated with an elevated risk for allergic rhinitis, a recent study shows.
  Medscape Medical News, April 02, 2025
• Safety of Combo Therapy for IMIDs Requires Caution ‘I think combination therapy is coming; it’s just a question of which combinations,’ says Arthur Kavanaugh, MD.
  Medscape Medical News, April 01, 2025
• Trump Begins Mass Layoffs At FDA, CDC, Other US Health Agencies The Trump administration began mass layoffs of 10,000 staffers at U.S. health agencies on Tuesday, according to multiple sources familiar with the situation, with security...
  Reuters Health Information, April 01, 2025
• Kids Are Primary Household RSV Spreaders Genomic sequencing shows most household spread of RSV is by children aged 6 months to 12 years.
  Medscape Medical News, April 01, 2025
• Should You Interrupt Arthritis DMARDs During an Infection? By pausing DMARDs, you may be ‘starting the cascade of getting the patient into trouble by interrupting therapy that’s working,’ said Jack Cush, MD.
  Medscape Medical News, April 01, 2025
• Designing a New Medical School Offers Chance for Creativity From designing the curriculum to recruiting faculty and students, building a medical school from the ground up is a unique experience.
  Medscape Medical News, April 01, 2025
• Dietary Counseling Benefits Children With Food Allergies Dietary counseling is an effective strategy for managing and preventing nutritional imbalances in pediatric patients with non–IgE-mediated gastrointestinal food allergies, a study shows.
  Medscape Medical News, March 31, 2025
• French Agency Seeks Endocrine Disruptor Label for Resorcinol New findings suggest that resorcinol may disrupt hormone systems and cause serious health issues, prompting regulatory action to safeguard public health.
  Medscape News UK, March 31, 2025
• Young Vitiligo Patients Face Hurdles to UVB Therapy A patient survey highlights significant barriers to narrowband UVB phototherapy among children with vitiligo, including limited availability and insurance challenges.
  Medscape Medical News, March 31, 2025
• Low-Dose Doxycycline Effective in Scarring Alopecia A retrospective study finds that low-dose doxycycline is as effective as high-dose for lymphocytic scarring alopecia while reducing adverse effects and discontinuations.
  Medscape Medical News, March 28, 2025